Direct Association with Thioredoxin Allows Redox Regulation of Glucocorticoid Receptor Function*

The glucocorticoid receptor (GR) is considered to belong to a class of transcription factors, the functions of which are exposed to redox regulation. We have recently demonstrated that thioredoxin (TRX), a cellular reducing catalyst, plays an important role in restoration of GR function in vivo under oxidative conditions. Although both the ligand binding domain and other domains of the GR have been suggested to be modulated by TRX, the molecular mechanism of the interaction is largely unknown. In the present study, we hypothesized that the DNA binding domain (DBD) of the GR, which is highly conserved among the nuclear receptors, is also responsible for communication with TRX in vivo. Mammalian two-hybrid assay and glutathione S-transferase pull-down assay revealed the direct association between TRX and the GR DBD. Moreover, analysis of subcellular localization of TRX and the chimeric protein harboring herpes simplex viral protein 16 transactivation domain and the GR DBD indicated that the interaction might take place in the nucleus under oxidative conditions. Together these observations indicate that TRX, via a direct association with the conserved DBD motif, may represent a key mediator operating in interplay between cellular redox signaling and nuclear receptor-mediated signal transduction.

[1]  O. Jänne,et al.  Identification of a Novel RING Finger Protein as a Coregulator in Steroid Receptor-Mediated Gene Transcription , 1998, Molecular and Cellular Biology.

[2]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[3]  J. T. Kadonaga Eukaryotic Transcription: An Interlaced Network of Transcription Factors and Chromatin-Modifying Machines , 1998, Cell.

[4]  Y. Makino,et al.  Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. , 1997, Nucleic acids research.

[5]  M. Matsui,et al.  Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[6]  B. Segnitz,et al.  The Function of Steroid Hormone Receptors Is Inhibited by the hsp90-specific Compound Geldanamycin* , 1997, The Journal of Biological Chemistry.

[7]  C. Hänni,et al.  Ligand binding was acquired during evolution of nuclear receptors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Schreiber,et al.  Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase , 1997, Cell.

[9]  K. Mori,et al.  AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Glass,et al.  Nuclear receptor coactivators. , 1997, Current opinion in cell biology.

[11]  T. Curran,et al.  Identification of redox/repair protein Ref-1 as a potent activator of p53. , 1997, Genes & development.

[12]  S. Minoguchi,et al.  Cloning and characterization of the nucleoredoxin gene that encodes a novel nuclear protein related to thioredoxin. , 1997, Genomics.

[13]  Yoshiaki Ito,et al.  Functional Dissection of the α and β Subunits of Transcription Factor PEBP2 and the Redox Susceptibility of Its DNA Binding Activity* , 1996, The Journal of Biological Chemistry.

[14]  H. Masutani,et al.  Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I Tax. , 1996, Immunology letters.

[15]  K. Umesono,et al.  Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. , 1996, The Journal of clinical investigation.

[16]  M. Matsui,et al.  Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. , 1996, Developmental biology.

[17]  K. Dahlman-Wright,et al.  Modulation of glucocorticoid-inducible gene expression by metal ions. , 1996, Molecular Pharmacology.

[18]  Sánchez,et al.  Immunophilins, Heat Shock Proteins, and Glucocorticoid Receptor Actions in Vivo , 1996, Methods.

[19]  K. Webster,et al.  Physical and functional sensitivity of zinc finger transcription factors to redox change , 1996, Molecular and cellular biology.

[20]  Y. Makino,et al.  Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. , 1996, Journal of immunology.

[21]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[22]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[23]  K. Umesono,et al.  Localization, trafficking, and temperature-dependence of the Aequorea green fluorescent protein in cultured vertebrate cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  B. O’Malley,et al.  Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.

[25]  J. Cidlowski,et al.  Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant glucocorticoid receptors , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  K. Dahlman-Wright,et al.  Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations. , 1995, Molecular pharmacology.

[27]  J. Yodoi,et al.  Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. , 1995, Cancer research.

[28]  S. Lindquist,et al.  Mutational analysis of Hsp90 function: interactions with a steroid receptor and a protein kinase , 1995, Molecular and cellular biology.

[29]  Jeffrey R. Huth,et al.  Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NFκB , 1995 .

[30]  A. Holmgren,et al.  Thioredoxin structure and mechanism: conformational changes on oxidation of the active-site sulfhydryls to a disulfide. , 1995, Structure.

[31]  W. Pratt,et al.  [39] Glucocorticoid receptor thiols andsteroid-binding activity , 1995 .

[32]  K. Schulze-Osthoff,et al.  Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Curran,et al.  The redox and DNA-repair activities of Ref-1 are encoded by nonoverlapping domains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  A. H. Myrset,et al.  DNA and redox state induced conformational changes in the DNA‐binding domain of the Myb oncoprotein. , 1993, The EMBO journal.

[35]  K. Umesono,et al.  Determinants for selective RAR and TR recognition of direct repeat HREs. , 1993, Genes & development.

[36]  P. Baeuerle,et al.  H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor. , 1993, The EMBO journal.

[37]  E. Adamson,et al.  Characterization of the DNA-binding properties of the early growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism. , 1993, DNA and cell biology.

[38]  B. Wasylyk,et al.  Oncogenic conversion of Ets affects redox regulation in-vivo and in-vitro. , 1993, Nucleic acids research.

[39]  T. Curran,et al.  Redox activation of Fos‐Jun DNA binding activity is mediated by a DNA repair enzyme. , 1992, The EMBO journal.

[40]  R D Klausner,et al.  Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Yodoi,et al.  Thiordoxin regulates the DNA binding activity of NF-χB by reduction of a disulphid bond involving cysteine 62 , 1992 .

[42]  J. Yodoi,et al.  Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. , 1992, International immunology.

[43]  K. Yamamoto,et al.  Role of cysteines 640, 656, and 661 in steroid binding to rat glucocorticoid receptors. , 1992, The Journal of biological chemistry.

[44]  T. Curran,et al.  Identification and characterization of Ref‐1, a nuclear protein that facilitates AP‐1 DNA‐binding activity. , 1992, The EMBO journal.

[45]  E. R. Sánchez Heat shock induces translocation to the nucleus of the unliganded glucocorticoid receptor. , 1992, The Journal of biological chemistry.

[46]  L. Poellinger,et al.  Assembly of a glucocorticoid receptor complex prior to DNA binding enhances its specific interaction with a glucocorticoid response element. , 1991, The Journal of biological chemistry.

[47]  L. Poellinger,et al.  High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. Demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein. , 1991, The Journal of biological chemistry.

[48]  S. Meshinchi,et al.  Redox manipulation of DNA binding activity and BuGR epitope reactivity of the glucocorticoid receptor. , 1991, The Journal of biological chemistry.

[49]  W. Leonard,et al.  Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Iwata Satoshi,et al.  Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reduction. , 1990 .

[51]  T. Curran,et al.  Redox regulation of fos and jun DNA-binding activity in vitro. , 1990, Science.

[52]  K. Arai,et al.  ATL‐derived factor (ADF), an IL‐2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol‐reduction in the IL‐2 receptor induction. , 1989, The EMBO journal.

[53]  S. McKnight,et al.  Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. , 1988, Genes & development.

[54]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[55]  K. Yamamoto,et al.  Two signals mediate hormone‐dependent nuclear localization of the glucocorticoid receptor. , 1987, The EMBO journal.

[56]  Jun Ma,et al.  A new class of yeast transcriptional activators , 1987, Cell.

[57]  R. Evans,et al.  Functional domains of the human glucocorticoid receptor , 1986, Cell.

[58]  A. Holmgren,et al.  Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin. , 1985, The Journal of biological chemistry.

[59]  N. Holbrook,et al.  Sulfhydryl-modifying reagents reversibly inhibit binding of glucocorticoid-receptor complexes to DNA-cellulose. , 1984, Biochemistry.